PLAY PODCASTS
Neurodevelopmental Effects of Antenatal IV Magnesium Sulfate Between 30-34 Weeks' Gestation

Neurodevelopmental Effects of Antenatal IV Magnesium Sulfate Between 30-34 Weeks' Gestation

JAMA Author Interviews · American Medical Association

August 15, 202313m 31s

Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Magnesium sulfate is widely recommended for neuroprotection in pregnancies at risk of preterm delivery. However, the optimal gestational age for use is unclear. JAMA Associate Editor Melissa Simon, MD, MPH, and Caroline Crowther, MD, Liggins Institute, University of Auckland, discuss the use of magnesium sulfate at different gestational ages and potential benefit vs harms as reflected in the MAGENTA Trial. Related Content: